Luofu Wang

1.2k total citations
44 papers, 907 citations indexed

About

Luofu Wang is a scholar working on Biomedical Engineering, Molecular Biology and Surgery. According to data from OpenAlex, Luofu Wang has authored 44 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 13 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Luofu Wang's work include Ultrasound and Hyperthermia Applications (14 papers), Photoacoustic and Ultrasonic Imaging (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Luofu Wang is often cited by papers focused on Ultrasound and Hyperthermia Applications (14 papers), Photoacoustic and Ultrasonic Imaging (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Luofu Wang collaborates with scholars based in China, United States and Panama. Luofu Wang's co-authors include Yanli Guo, Kejing Fang, Xiaozhou Fan, Weihua Lan, Jun Jiang, Qiuli Liu, Haipeng Tong, Dianzheng Zhang, Dali Tong and Lang Li and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Nanoscale.

In The Last Decade

Luofu Wang

44 papers receiving 890 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luofu Wang China 19 355 337 180 127 125 44 907
Jiale Qin China 17 264 0.7× 212 0.6× 162 0.9× 177 1.4× 110 0.9× 62 793
Ningning He China 19 534 1.5× 155 0.5× 168 0.9× 223 1.8× 189 1.5× 64 1.1k
Bock Lim Australia 13 293 0.8× 155 0.5× 109 0.6× 88 0.7× 73 0.6× 16 807
Jianping Dou China 20 319 0.9× 448 1.3× 141 0.8× 79 0.6× 120 1.0× 61 1.2k
Yolanda E. Hartman United States 14 205 0.6× 586 1.7× 293 1.6× 76 0.6× 209 1.7× 23 1.1k
Huibo Lian China 18 255 0.7× 166 0.5× 337 1.9× 109 0.9× 61 0.5× 39 773
Jianzhou Liu China 17 291 0.8× 127 0.4× 104 0.6× 190 1.5× 117 0.9× 65 929
Shenghan Lou China 16 341 1.0× 127 0.4× 146 0.8× 115 0.9× 230 1.8× 49 885
Yongyang Yu China 19 304 0.9× 243 0.7× 173 1.0× 248 2.0× 410 3.3× 63 1.1k
Shichao Ai China 15 187 0.5× 300 0.9× 257 1.4× 151 1.2× 155 1.2× 38 806

Countries citing papers authored by Luofu Wang

Since Specialization
Citations

This map shows the geographic impact of Luofu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luofu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luofu Wang more than expected).

Fields of papers citing papers by Luofu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luofu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luofu Wang. The network helps show where Luofu Wang may publish in the future.

Co-authorship network of co-authors of Luofu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Luofu Wang. A scholar is included among the top collaborators of Luofu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luofu Wang. Luofu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ze, Peng Song, Jian Chen, et al.. (2024). Histone demethylase PHF8 promotes prostate cancer metastasis via the E2F1SNAI1 axis. The Journal of Pathology. 264(1). 68–79. 2 indexed citations
2.
Wang, Shuo, Weihua Lan, Yapeng Wang, et al.. (2024). Genetic Alterations in Chromatin Regulatory Genes in Upper Tract Urothelial Carcinoma and Urothelial Bladder Cancer. Cancer Medicine. 13(21). e70398–e70398. 1 indexed citations
3.
Wang, Luofu, et al.. (2024). Advances in and prospects of immunotherapy for prostate cancer. Cancer Letters. 601. 217155–217155. 19 indexed citations
4.
Lan, Weihua, Luofu Wang, Dianzheng Zhang, et al.. (2023). PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma. Science Advances. 9(31). eadf3566–eadf3566. 17 indexed citations
5.
Tang, Peng, Jun Zhang, Peng Song, et al.. (2023). Genotype-phenotype correlation in patients with 21-hydroxylase deficiency. Frontiers in Endocrinology. 14. 1095719–1095719. 2 indexed citations
6.
Deng, Liu, et al.. (2023). Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma. International Journal of Nanomedicine. Volume 18. 2757–2776. 9 indexed citations
7.
Tang, Peng, Tang Tang, Yapeng Wang, et al.. (2022). Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases. 26(1). 180–187. 9 indexed citations
8.
Yu, Zhiping, Dan Xu, Yanli Guo, et al.. (2020). Anti-G250 nanobody-functionalized nanobubbles targeting renal cell carcinoma cells for ultrasound molecular imaging. Nanotechnology. 31(20). 205101–205101. 29 indexed citations
9.
Tang, Tang, Jian Pang, Jing Xu, et al.. (2020). LSD1 Promotes Bladder Cancer Progression by Upregulating LEF1 and Enhancing EMT. Frontiers in Oncology. 10. 1234–1234. 34 indexed citations
10.
Liu, Qiuli, Jian Pang, Jing Xu, et al.. (2020). Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2. The Journal of Pathology. 253(1). 106–118. 48 indexed citations
11.
Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2018). Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration. Clinical Cancer Research. 24(22). 5622–5634. 86 indexed citations
12.
Liu, Qiuli, Dali Tong, Jing Xu, et al.. (2018). A novel germline ARMC5 mutation in a patient with bilateral macronodular adrenal hyperplasia: a case report. BMC Medical Genetics. 19(1). 49–49. 9 indexed citations
13.
Wang, Luofu, et al.. (2018). CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors. International Journal of Nanomedicine. Volume 13. 6481–6495. 35 indexed citations
14.
Guo, Yanli, Luofu Wang, Xiaozhou Fan, et al.. (2017). Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs. Journal of Nanobiotechnology. 15(1). 63–63. 22 indexed citations
15.
Fan, Xiaozhou, et al.. (2016). Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction. International Journal of Nanomedicine. Volume 11. 3585–3596. 45 indexed citations
16.
Fan, Xiaozhou, et al.. (2016). Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles. International Journal of Nanomedicine. Volume 11. 3939–3950. 53 indexed citations
17.
Fan, Xiaozhou, Luofu Wang, Yanli Guo, et al.. (2015). Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging. PLoS ONE. 10(6). e0127419–e0127419. 66 indexed citations
18.
Tong, Haipeng, Luofu Wang, Yanli Guo, et al.. (2013). Preparation of Protamine Cationic Nanobubbles and Experimental Study of Their Physical Properties and In Vivo Contrast Enhancement. Ultrasound in Medicine & Biology. 39(11). 2147–2157. 22 indexed citations
19.
Fan, Xiaozhou, Luofu Wang, Yanli Guo, et al.. (2013). Experimental investigation of the penetration of ultrasound nanobubbles in a gastric cancer xenograft. Nanotechnology. 24(32). 325102–325102. 31 indexed citations
20.
Zhang, Ke‐Qin, Gui‐lian Xu, Yanfeng Li, et al.. (2009). Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth. Cancer Immunology Immunotherapy. 59(1). 93–101. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026